Know Cancer

or
forgot password
  • cancer clinical trials in boise, ID

  • Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Lymphoma
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Neuroblastoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Brain and Central Nervous System Tumors
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Lung Cancer
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Prostate Cancer, Sexual Dysfunction
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Prostate Cancer
    Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
    Mountain States Tumor Institute Mountain States
    Boise, Idaho 83712
    Myelodysplastic Syndromes
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Saint Alphonsus Regional Medical Center

    Trial Locations
    Saint Alphonsus Regional Medical Center
    Saint Luke's Mountain States Tumor Institute
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Ovarian Cancer, Sarcoma
    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Head and Neck Cancer
    Study of Blood Samples From Newborns With Down Syndrome
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Leukemia
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Melanoma (Skin)
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Study of Tissue and Blood Samples From Patients With High-Grade Glioma
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Brain and Central Nervous System Tumors
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Colorectal Cancer, Precancerous Condition
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Lung Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Lung Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Malignant Mesothelioma
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Breast Cancer
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Saint Luke's Mountain States Tumor Institute
    Lung Cancer
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Leukemia
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Saint Luke's Mountain States Tumor Institute
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Head and Neck Cancer
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Prostate Cancer
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Saint Luke's Mountain States Tumor Institute
    Breast Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Saint Alphonsus Regional Medical Center

    Trial Locations
    Saint Alphonsus Regional Medical Center
    Saint Luke's Mountain States Tumor Institute
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma